Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)

• Asıl Yazarlar: Heublein Sabine (Yazar), Vrekoussis Thomas (Yazar), Mayr Doris (Yazar), Friese Klaus (Yazar), Lenhard Miriam (Yazar), Jeschke Udo (Yazar), Dian Darius (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2013-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Anti-Her-2 treatment is successfully administered to Her-2 overexpressing breast cancer patients and significantly implicates upon their survival. Building on these promising results, anti-Her-2 treatment protocols were tested as an...